In a 6-month clinical study, versus latanoprost, a statistically superior reduction in morning mean IOP (ranging from -7.6 to -8.2 mmHg for bimatoprost versus – 6.0 to – 7.2 mmHg for latanoprost) was observed at all visits throughout the study.